Subcutaneous morphine for dyspnea in cancer patients.
Bruera
E
E
Edmonton General Hospital, Alberta, Canada.
MacEachern
T
T
Ripamonti
C
C
Hanson
J
J
D002245:Carbon Dioxide / Q000502:physiology; D004417:Dyspnea / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007279:Injections, Subcutaneous; D009020:Morphine / Q000008:administration & dosage*; D009369:Neoplasms / Q000150:complications*; D010100:Oxygen / Q000097:blood; D012119:Respiration / Q000187:drug effects; D013727:Terminal Care; D013990:Tidal Volume
D002245:Carbon Dioxide; D009020:Morphine; D010100:Oxygen